CG
KZR

Cutler Group’s Kezar Life Sciences KZR Stock Holding History

Cutler Group’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2K Hold
240
– – ﹤0.01% 1857
2023
Q4 		$2K Sell
240
-530
-69% -$4.66K ﹤0.01% 3122
2023
Q3 		$9K Buy
770
+400
+108% +$7.09K ﹤0.01% 2532
2023
Q2 		$9K Buy
370
+100
+37% +$2.6K ﹤0.01% 2306
2023
Q1 		$8K Hold
270
– – ﹤0.01% 2469
2022
Q4 		$19K Sell
270
-208
-44% -$15.4K ﹤0.01% 2255
2022
Q3 		$41K Sell
478
-1,089
-69% -$106K ﹤0.01% 2041
2022
Q2 		$129K Buy
+1,567
New +$138K 0.01% 1273
2021
Q1 		– Sell
-10
Closed – – 5988
2020
Q4 		$0 Sell
10
-10
-50% -$556 ﹤0.01% 5179
2020
Q3 		$0 Buy
20
+10
+100% +$478 ﹤0.01% 5001
2020
Q2 		$0 Buy
+10
New +$505 ﹤0.01% 4644

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cutler Group's KZR Position: Q1 2024 in Review

Cutler Group held its Kezar Life Sciences (KZR) position steady in Q1 2024 at 240 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Cutler Group first reported a position in KZR in Q2 2020 and has held it in 11 quarters since. The position peaked at $129K in Q2 2022. 85 funds tracked by Wall St. Rank hold KZR as of Q1 2024.

  • Cutler Group held 240 shares of Kezar Life Sciences worth $2K as of Q1 2024.
  • Cutler Group left its Kezar Life Sciences share count unchanged in Q1 2024.
  • Kezar Life Sciences made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1857 holding.
  • Cutler Group first reported a position in Kezar Life Sciences in Q2 2020 and has held it in 11 quarters since.
  • Cutler Group's Kezar Life Sciences position peaked at $129K in Q2 2022.
  • 85 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.